Altamira Therapeutics Ltd...
(CYTO)
undefined
undefined%
At close: undefined
0.47
5.98%
Pre-market Dec 16, 2024, 08:52 AM EST
Altamira Therapeutics Ltd. Forcast
Stock Price Forecast
The 0 analysts with 12-month price forecasts for CYTO stock have an median target of 0, with a low estimate of 0 and a high estimate of 0. The median target predicts a decrease of 0% from the current stock price of 0.44.
Analyst Consensus: undefined
AI Analyst Report
According to 0 stock analyst, the rating for Altamira Therapeutics Ltd. is "undefined". This means that the analyst believes this stock is likely to lead to similar returns than market as a whole.
Financial Forecast this Year
Revenue This Year
n/a
Revenue Next Year
0
from 0
Increased by -%
EPS This Year
-2.23
from -14.81
Increased by 84.9%
EPS Next Year
-0.98
from -2.23
Increased by 56.1%